Mirtazapin Spirig HC 45 mg, Filmtabletten - 30 Swissmedic Key 69879007 Registration Holder Spirig HealthCare AG Name Mirtazapin Spirig HC 45 mg, Filmtabletten Date of registration 11.07.2025 Introduction of Sequence 11.07.2025 ATC-Classification Mirtazapine (N06AX11) Revision date WHO WHO-DDD Valid until 10.07.2030 Index Therapeuticus (BSV) Show package size 30 Index Therapeuticus (Swissmedic) 01.06. Description Swissmedic categorie. B SL Eintrag No Indication Information for professionals Consumer information Ex-factory-Price PR Deductible k.A. Consumer price PR Feedback FB GTIN 7680698790075 Medication Code Synthetika Pharmacode Disponibility
Composition mirtazapinum 45 mg, lactosum monohydricum 305.4 mg, amylum pregelificatum, silica colloidalis anhydrica, carmellosum natricum conexum corresp. natrium 0.78 mg, magnesii stearas, Überzug: hypromellosum, macrogolum 8000, E 171, talcum, pro compresso obducto. Packungsbestandteile Galenic Form Coated tablets Active Agent Dose Mirtazapine 45 mg
Inactive agents Dose additional_information color. Hypromellosum Überzug Lactose Monohydrate 305.4 mg Macrogol 8000 Silica Colloidalis Anhydrica Talcum
Source Data was imported : 07.08.2025
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
